Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs) EQUITY
$113.35
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | JNJ Avg Daily Volume: 7,510,600
Last Update: 05/25/16 - 4:00 PM EDT
Volume: 0
YTD Performance: 10.35%
Open: $0.00
Previous Close: $113.35
52 Week Range: $81.79 - $115.00
Oustanding Shares: 2,750,644,288
Market Cap: 309,970,104,815
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 7
Moderate Buy 2 2 1 1
Hold 8 7 6 6
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 0
Mean Rec. 2.22 2.18 2.13 1.93
Latest Dividend: 0.80
Latest Dividend Yield: 2.84%
Dividend Ex-Date: 05/20/16
Price Earnings Ratio: 16.38
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
16.38 20.50 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
6.55% 11.84% 30.56%
GROWTH 12 Mo 3 Yr CAGR
Revenue -5.70 0.00 0.01
Net Income -5.60 0.50 0.13
EPS -3.90 0.40 0.12
Earnings for JNJ:
EBITDA 22.04B
Revenue 70.07B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $1.67 $1.64 $6.60 $6.99
Number of Analysts 10 8 12 11
High Estimate $1.71 $1.67 $6.63 $7.10
Low Estimate $1.63 $1.60 $6.58 $6.71
Prior Year $1.71 $1.49 $6.20 $6.60
Growth Rate (Year over Year) -2.51% 10.32% 6.37% 5.95%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Jim Cramer

 | May 16, 2016 | 1:29 PM EDT

Many familiar names, but are any worth buying?

By

James Passeri

 | May 12, 2016 | 9:17 AM EDT

Coming off a brutal first quarter, Bill Ackman's hedge fund announced the loss of a key strategist.

By

David Katz

 | May 11, 2016 | 7:00 AM EDT

The expected legal deluge will be manageable thanks to JNJ's massive size and financial strength.

By

Sham Gad

 | May 10, 2016 | 2:00 PM EDT

Think of what dividends can do.

By

Jim Cramer

 | May 6, 2016 | 12:35 PM EDT

There is an overall flow of funds out of the stock market after a weak jobs report.

By

Jim Cramer

 | May 4, 2016 | 11:00 AM EDT

Investors are going to rotate back into safety stocks if the April jobs number disappoints on Friday, says TheStreet's Jim Cramer.

bullishJohnson & Johnson numbers raised at Jefferies

May 4, 2016 | 7:03 AM EDT

Shares of JNJ now seen reaching $110, according to Jefferies. Estimates also increased, given higher expected pharma growth. Hold rating. 

By

Jim Cramer

 | Apr 28, 2016 | 3:49 PM EDT

It has pivoted from desktop dinosaur to mobile monster in no time flat.

By

Jim Cramer

 | Apr 28, 2016 | 11:11 AM EDT

Jim Cramer believes the pharmaceutical sector has come full circle and some of the best stocks in the group are ready to move higher.

updateJNJ Investor Mtg.

Apr 28, 2016 | 7:02 AM EDT

JNJ - Johnson & Johnson Annual Shareholders Meeting - 10AM

Bunge (NYSE:BG) declared a $0.42/share quarterly dividend, a 10.5% increase from its prior...
Today's strength in ES (Emini S&P 500) ripped above the May 10 high at 2079.75. This i...
Record call volume in Craft Brew Alliance after four day rally. Shares up nearly 5% near $...
Market having another strong day. Energy shares strong as oil tries to broach $50 a barre...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.